CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

828 results.
Study Number Lead Group Study Title CIRB Study Status
A221805 Alliance Duloxetine to Prevent Oxaliplatin-Induced Chemotherapy-Induced Peripheral Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase II to Phase III Study Cancer Prevention and Control CIRB Available to Open
WF-10217 NCORP-Wake Forest University Work Ability in Young Adult Survivors (WAYS) Cancer Prevention and Control CIRB Available to Open
E1Q11 ECOG EROS: Engendering Reproductive Health within Oncologic Survivorship Cancer Prevention and Control CIRB Available to Open
WF-1802 NCORP-Wake Forest University Influence of Primary Treatment for Prostate Cancer on Work Experience (PCW) Cancer Prevention and Control CIRB Available to Open
NWU2015-06-02 CLO-Northwestern University Immunogenicity of Nonavalent HPV Vaccine Administered Prior To Living Donor Renal Transplantation in Adult Women: A Prospective, Single-Arm, Multi-Center Clinical Trial Cancer Prevention and Control CIRB Available to Open
URCC-19085 NCORP-University of Rochester Cancer Center Wireless Transcutaneous Electrical Nerve Stimulation (TENS) For Chemotherapy-Induced Peripheral Neuropathy: A Phase II Clinical Trial Cancer Prevention and Control CIRB Available to Open
UWI2016-07-01 CLO-University of Wisconsin Phase IIB Randomized, Placebo-Controlled Trial of ACTOplus met® XR in Subjects with Stage I-IV Squamous Cell Carcinoma of the Oral Cavity or Oropharynx Prior to Definitive Treatment Cancer Prevention and Control CIRB Available to Open
DCP-001 NCI Use of a Clinical Trial Screening Tool to Address Cancer Health Disparities in the NCI Community Oncology Research Program (NCORP) Cancer Prevention and Control CIRB Available to Open
828 results.